PEGFILGRASTIM-JMDB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-JMDB was used for Neoplasm malignant.
Most Reported Side Effects for PEGFILGRASTIM-JMDB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 51 | 17.0% | 50 | 1 |
| Product quality issue | 21 | 7.0% | 0 | 0 |
| Drug ineffective | 20 | 6.7% | 3 | 12 |
| Device leakage | 17 | 5.7% | 0 | 0 |
| Hospitalisation | 15 | 5.0% | 1 | 14 |
| Needle issue | 14 | 4.7% | 0 | 0 |
| Neutropenia | 13 | 4.3% | 2 | 7 |
| Febrile neutropenia | 12 | 4.0% | 1 | 6 |
| Nausea | 11 | 3.7% | 1 | 5 |
| Off label use | 11 | 3.7% | 0 | 0 |
| Device issue | 10 | 3.3% | 0 | 0 |
| Vomiting | 10 | 3.3% | 1 | 8 |
| Pyrexia | 9 | 3.0% | 1 | 7 |
| Device breakage | 8 | 2.7% | 0 | 0 |
| Device defective | 8 | 2.7% | 2 | 2 |
Other Indications for PEGFILGRASTIM-JMDB
Product used for unknown indication (128)
Neutropenia (22)
Febrile neutropenia (12)
Agranulocytosis (10)
Chemotherapy (9)
Prophylaxis (9)
Breast cancer (7)
Ovarian cancer (6)
Diffuse large b-cell lymphoma (5)
Malignant connective tissue neoplasm (5)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)